Hsiao D. Lieu - Jan 16, 2024 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
EVP, CHIEF MEDICAL OFFICER
Signature
/s/ Valerie Pierce, Attorney-in-Fact
Stock symbol
NGM
Transactions as of
Jan 16, 2024
Transactions value $
-$7,276
Form type
4
Date filed
1/18/2024, 06:03 PM
Previous filing
Nov 8, 2023
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Tax liability -$7.28K -5.43K -9.1% $1.34 54.3K Jan 16, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
F2 Includes 3,717 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on May 15, 2023 and 362 ESPP shares acquired on November 15, 2023.